abstract |
The present invention relates to a chimeric T-cell receptor (Synthetic T-Cell Receptor and Antigen Receptor, STAR), and relevant preparations and drugs, or the use of same in preparing drugs for cells, and also relates to the use of the preparations or pharmaceutical compositions for treating corresponding diseases, such as tumours or infectious diseases. |